Tirzeparo – Dual GIP/GLP-1 Agonist Peptide

Tirzeparo is a dual-acting incretin agonist that stimulates GIP and GLP-1 receptors simultaneously, making it ideal for advanced weight-loss and metabolic studies.

Use Cases:

• Dual-hormone modelling
• Long-acting GLP-1 agonist comparisons
• Appetite and energy balance research

Strengths: 2.5mg to 15mg pens

Delivered with full research-only documentation.